Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Holmgren, Anders
TACSI, NCT03560310 / 2017-001499-43: Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome	Active, not recruiting	4	2203	Europe, RoW	Ticagrelor 90mg twice daily and ASA 75-100 mg daily, ASA 75-160 mg daily	Vastra Gotaland Region, Gothia Forum - Center for Clinical Trial, The Sahlgrenska Academy at University of Gothenburg	Acute Coronary Syndrome	03/25	02/35